CUSIP: 23282W605
Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
122,181,876
-
Total 13F shares
-
138,460,393
-
Share change
-
-3,233,208
-
Total reported value
-
$8,797,875,052
-
Put/Call ratio
-
26%
-
Price per share
-
$63.54
-
Number of holders
-
427
-
Value change
-
-$178,140,331
-
Number of buys
-
224
-
Number of sells
-
183
Quarterly Holders Quick Answers
What is CUSIP 23282W605?
CUSIP 23282W605 identifies CYTK - CYTOKINETICS INC - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q4 2025
As of 31 Dec 2025,
CYTOKINETICS INC - COMMON STOCK (CYTK) was held by
427 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
138,460,393 shares.
The largest 10 holders included
T. Rowe Price Investment Management, Inc., BlackRock, Inc., FMR LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Deep Track Capital, LP, GEODE CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, and RTW INVESTMENTS, LP.
This page lists
427
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.